Work

Supplementary Figure 2 from Defining the Functional Role and Potential as an Immunotherapeutic Target of ALCAM in Neuroblastoma

Year: 2026

Type: supplementary-materials

Abstract: MYCN binding to GP2 and ODC1 and enhancer window ATAC.

DOI: 10.1158/1535-7163.31923208

Authors: Jarrett Lindsay, Jonathan Gaither, David Groff, Minu Samanta, Rebecca Kaufman, Liron Grossmann, Nicholas Hartnett, Nathan Kendsersky, Emily A. Mycek, Sharon J. Diskin, John M. Maris

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7147075728

Cites:

Cited by:

Related to: 10